For investors, it can be quite challenging to decide if the Advance Agrolife IPO is a good investment or not. If you are unsure and still thinking about whether to apply or skip this IPO, don’t worry. In this article, we bring you the top important key factors and a detailed review of the Advance Agrolife IPO. This will help you analyze the strengths, risks, and financial details of Advance Agrolife, making your investment decision better.
About Company
Advance Agrolife Limited, founded in February 2002, is engaged in the manufacturing of a wide range of agrochemical products. Advance Agrolife mostly focuses on producing effective products such as insecticides, herbicides, fungicides, and plant growth regulators. Its products are used in the farming of various products, including cereals, vegetables, and horticultural crops, in India.
Moreover, advance agrolife also involved in the manufacturing of agrochemical products incudes micro-nutrient fertilizers and biofertilizers. Their products are mainly sold domestically through direct sales to corporate customers on a B2B basis. In FY24, the company generated a revenue of ₹455 crore from operations, whereas also generated a Net Profit after tax of ₹24 crore respectively. Its products are sold throughout 19 states, and 3 union territories, exporting across 7 countries including UAE, Bangladesh, china, turkey, Egypt, Kenya, and Nepal.
Strengths
- The company comes with a Well-established, fully integrated manufacturing unit at a strategic location.
- They offer a wide range of agrochemical products.
- Epack prefab comes with an established customer base and strong relationships.
- The company has shown a strong track record of healthy growth.
Weaknesses
- The company runs its business in India with a limited presence in international markets.
- Any changes in government policies or cuts in farmer subsidies may harm the business.
- Unable to meet the quality standards in India or abroad can badly affect the business and its reputation.
- A large part of the revenue comes from a few customers, meaning losing any of them can badly impact the business and cash flow.
Advance Agrolife IPO Review
| Reviewer | Recommendation |
| IPO Watch | May Apply |
| Capital Market | Neutral |
| Canara Bank | |
| DRChoksey FinServ | |
| Emkay Global | |
| Hem Securities | |
| IDBI Capital | |
| Marwadi Shares | |
| Nirmal Bang | |
| SBICAP Securities | |
| Sharekhan | |
| SMC Global | |
| Sushil Finance | |
| Swastika Investmart | |
| Ventura Securities | |
| Geojit | |
| Reliance Securities | |
| BP Wealth | |
| ICICIdirect | |
| Choice Broking |
Advance Agrolife IPO Details
| IPO Open Date: | September 30, 2025 |
| IPO Close Date: | October 3, 2025 |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹95 to ₹100 Per Share |
| Issue Size: | Approx ₹192.86 Crores |
| Fresh Issue: | Approx ₹192.86 Crores |
| Issue Type | Book Built Issue |
| Registrar | Kfin Technologies Ltd. |
| IPO Lead Managers | Choice Capital Advisors Private Limited |
| Basis of Allotment | October 6, 2025 |
| IPO Listing Date: | October 8, 2025 |
| Listing | BSE, NSE |
Financial Performance Trend Details
| Particulars | Fiscal 2025 | Fiscal 2024 | Fiscal 2023 |
| Total Income | ₹502.88 Crores | ₹457.21 Crores | ₹397.97 Crores |
| EBITDA | ₹48.25 Crores | ₹40.21 Crores | ₹25.22 Crores |
| EBITDA Margin (%) | 9.61% | 8.82% | 6.34% |
| Net Profit after Tax | 25.64 | 24.73 | 14.87 |
| Net Profit Margin (%) | 5.10% | 5.42% | 3.74% |
| Net Worth | ₹100.87 Crores | ₹75.26 Crores | ₹50.60 Crores |
| Return on Capital Employed | 27.02% | 37.62% | 34.38% |
| Reserves and Surplus | ₹55.87 crores | ₹70.76 crores | ₹46.10 crores |
| Total Borrowings | ₹80.45 Crores | ₹45.46 Crores | ₹25.29 Crores |
Peer Comparison with the Company
| Name of the Company | Face Value per Equity Share (₹) | P/E | EPS (Basic) (₹) | RoNW (%) | NAV per Equity Share (₹) | EPS (Diluted) (₹) |
| Advance Agrolife Ltd | ₹10 | [●] | ₹5.70 | 29.11% | ₹22.42 | ₹5.70 |
| Dharmaj Crop Guard Limited | ₹10 | 34.60 | ₹10.68 | 9.24% | ₹116.70 | ₹10.3 |
| Insecticides India Limited | ₹10 | 16.99 | ₹48.38 | 13.55% | ₹372.74 | ₹48.38 |
| Heranba Industries Limited | ₹10 | – | ₹0.77 | 0.37% | ₹210.15 | ₹109.22 |
| PI Industries Limited | ₹10 | 34.29 | ₹109.44 | 17.58% | ₹668.22 | ₹109.22 |
| Sharda Cropchem Limited | ₹10 | 30.33 | ₹33.74 | 12.85% | ₹277.21 | ₹33.74 |
Promoters & Track Records, if any
- Om Prakash Choudhary, aged 40 years, is the Chairman and Managing Director of the Company. He holds 24,376,380 Equity Shares, representing 54.17% of the Paid-up Equity Share capital.
- Kedar Choudhary, aged 36 years, is a Whole Time Director of the Company. He holds 16,223,220 shares in the company, representing 36.05% of the paid-up Equity Share Capital.
- Geeta Choudhary, aged 42 years, is a Promoter of the Company. She holds 1,630,000 shares, representing 3.62% of paid-up equity shares in the company.
- Manisha Choudhary, aged 38 years, is a Promoter of the Company. She holds 1,476,400 shares, representing 3.28% of the shareholding in the company.
Information on Industry’s P/E Ratio
The company Advance Agrolife did not show the P/E ratio in the RHP. In the agrochemicals industry, the P/E ratio ranges from 16.99 to 34.60, with an average of 25.79.
Expansion
- The proceeds raised from the fresh issue will be utilized towards the Working Capital requirements of the Company.
- Some funds will be utilized for the company’s general corporate purposes.
Advance Agrolife IPO – Should You Apply or Not?
Advance Agrolife IPO comes with an Integrated Manufacturing Setup, a diverse product portfolio, and presence across domestic and export markets, making the company well-positioned towards future growth. Regulatory Risks, Limited customer base, and competitive pressures are some of the risks that investors should keep in mind before subscribing.
Investors may consider applying for the Advance Agrolife IPO, as the valuation appears reasonable and the sector shows healthy demand. Those with a higher risk appetite and a long-term investment perspective in the agrochemical industry may find this IPO attractive.
Please note:
Investors are advised to make their own decisions and apply entirely at their own risk. This article is written using information from the company’s RHP (Red Herring Prospectus) data and online sources. If you have any queries, kindly contact the IPO Watch Team.
